MT-2004

The goal of this randomized, double-blind, placebo controlled, Multicenter Phase II clinical trial is to initially evaluate the Safety and Efficacy of MT2004 Capsule in Cholestatic and Mixed drug induced liver injury (DILI) subjects.
The main questions it aims to answer are:
The Efficacy of MT2004 Capsule in Cholestatic and Mixed DILI subjects
The Safety and Pharmacokinetic characteristic of MT2004 Capsule in Cholestatic and Mixed DILI subjects
The mechanism of using MT2004 Capsule on Cholestatic and Mixed DILI subjects